Published in Genet Med on January 21, 2016
denovo-db: a compendium of human de novo variants. Nucleic Acids Res (2016) 0.79
A variant by any name: quantifying annotation discordance across tools and clinical databases. Genome Med (2017) 0.78
Gene Panel Testing in Epileptic Encephalopathies and Familial Epilepsies. Mol Syndromol (2016) 0.76
De novo and inherited SCN8A epilepsy mutations detected by gene panel analysis. Epilepsy Res (2016) 0.75
Mutations in HECW2 are associated with intellectual disability and epilepsy. J Med Genet (2016) 0.75
Neuronal deficiency of ARV1 causes an autosomal recessive epileptic encephalopathy. Hum Mol Genet (2016) 0.75
GNAO1 encephalopathy: Broadening the phenotype and evaluating treatment and outcome. Neurol Genet (2017) 0.75
When Should Genetic Testing Be Performed in Epilepsy Patients? Epilepsy Curr (2017) 0.75
The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients. Mol Diagn Ther (2017) 0.75
Incorrect dosage of IQSEC2, a known intellectual disability and epilepsy gene, disrupts dendritic spine morphogenesis. Transl Psychiatry (2017) 0.75
A Model Program for Translational Medicine in Epilepsy Genetics. J Child Neurol (2017) 0.75
Hotspots of missense mutation identify neurodevelopmental disorder genes and functional domains. Nat Neurosci (2017) 0.75
Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol (2009) 27.17
Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia (2010) 18.28
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med (2015) 16.87
Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med (2013) 15.85
Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics (2009) 15.08
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature (2012) 14.76
Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet (2011) 11.94
Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med (2012) 10.80
Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet (2012) 8.42
De novo mutations in epileptic encephalopathies. Nature (2013) 7.42
Molecular findings among patients referred for clinical whole-exome sequencing. JAMA (2014) 6.46
Diagnostic clinical genome and exome sequencing. N Engl J Med (2014) 5.55
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet (2013) 3.64
Large-scale discovery of novel genetic causes of developmental disorders. Nature (2014) 3.33
Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med (2014) 3.28
Points to consider in the clinical application of genomic sequencing. Genet Med (2012) 3.03
Exome sequencing can improve diagnosis and alter patient management. Sci Transl Med (2012) 2.70
Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet Med (2014) 2.41
Clinical whole exome sequencing in child neurology practice. Ann Neurol (2014) 2.32
De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. Am J Hum Genet (2014) 2.20
Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions. Genet Med (2014) 1.80
Exome sequencing reveals new causal mutations in children with epileptic encephalopathies. Epilepsia (2013) 1.78
The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders. Genet Med (2013) 1.65
Gene hunting in autism spectrum disorder: on the path to precision medicine. Lancet Neurol (2015) 1.62
Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nat Commun (2014) 1.59
The usefulness of whole-exome sequencing in routine clinical practice. Genet Med (2014) 1.48
Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis. Hum Mol Genet (2014) 1.46
Genetics of the epilepsies: where are we and where are we going? Curr Opin Neurol (2013) 1.38
GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy. Ann Neurol (2014) 1.34
Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. Epilepsia (2015) 1.31
Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome. Neurology (2013) 1.19
The hidden genetics of epilepsy-a clinically important new paradigm. Nat Rev Neurol (2014) 1.16
Whole-exome sequencing improves the diagnosis yield in sporadic infantile spasm syndrome. Clin Genet (2015) 1.01
Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome. Am J Hum Genet (2014) 0.99
COQ4 mutations cause a broad spectrum of mitochondrial disorders associated with CoQ10 deficiency. Am J Hum Genet (2015) 0.97
Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability. J Med Genet (2014) 0.93
CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems. J Neurodev Disord (2014) 0.92
Mutations in COQ4, an essential component of coenzyme Q biosynthesis, cause lethal neonatal mitochondrial encephalomyopathy. J Med Genet (2015) 0.84
Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain (2017) 0.79
De novo mutations of KIAA2022 in females cause intellectual disability and intractable epilepsy. J Med Genet (2016) 0.78
WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome. J Med Genet (2015) 0.78
GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects. J Med Genet (2017) 0.75
FOXG1 syndrome: genotype-phenotype association in 83 patients with FOXG1 variants. Genet Med (2017) 0.75